{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:57:32Z","timestamp":1787320652813,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.healun.2024.12.014","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T02:41:10Z","timestamp":1735526470000},"page":"975-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Incidence and risk factors for rejection after conversion from calcineurin inhibitor to sirolimus-based immunosuppression in orthotopic heart transplant recipients"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3200-3575","authenticated-orcid":false,"given":"Sara S.","family":"Inglis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0258-7402","authenticated-orcid":false,"given":"Rabea","family":"Asleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5518-8544","authenticated-orcid":false,"given":"Armin","family":"Garmany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9318-2437","authenticated-orcid":false,"given":"Byron H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-3469","authenticated-orcid":false,"given":"Naveen","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo L.","family":"Clavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1080-9471","authenticated-orcid":false,"given":"Mauricio A.","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-3539","authenticated-orcid":false,"given":"Philip J.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4266-0722","authenticated-orcid":false,"given":"Richard C.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta","family":"Behfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9202-0233","authenticated-orcid":false,"given":"Andrew N.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.12.014_bib1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","article-title":"Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency","volume":"12","author":"Zuckermann","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib2","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/ajt.12833","article-title":"Sirolimus conversion after heart transplant: risk factors for acute rejection and predictors of renal function response","volume":"14","author":"Zuckermann","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib3","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1111\/ajt.12832","article-title":"MTOR inhibitors as primary immunosuppression after heart transplant: confounding factors in clinical trials","volume":"14","author":"Kushwaha","year":"2014","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib5","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1111\/ajt.15361","article-title":"Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study","volume":"19","author":"Barten","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib6","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.107.692996","article-title":"Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation","volume":"116","author":"Raichlin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.12.014_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2024.12.014_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.tp.0000177644.45192.a3","article-title":"Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up","volume":"81","author":"Bestetti","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.12.014_bib10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","article-title":"Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure","volume":"87","author":"Groetzner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.12.014_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.TP.0000103740.98095.14","article-title":"Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac transplant recipients with chronic renal failure","volume":"77","author":"Groetzner","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.12.014_bib12","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.healun.2005.02.018","article-title":"Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation","volume":"24","author":"Hunt","year":"2005","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2007.07.034","article-title":"Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction","volume":"26","author":"Gustafsson","year":"2007","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/ajt.13588","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study","volume":"16","author":"Andreassen","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0000000000002702","article-title":"Initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: long-term follow-up from the randomized SCHEDULE study","volume":"104","author":"Gustafsson","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.12.014_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/TP.0b013e3181cbac2d","article-title":"Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial","volume":"89","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.12.014_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2018.03.111","article-title":"Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: a meta-analysis","volume":"265","author":"Jennings","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2024.12.014_bib18","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1016\/j.transproceed.2009.06.236","article-title":"Usefulness of sirolimus as rescue therapy in heart transplant recipients with renal failure: analysis of the Spanish Multicenter Observational Study (RAPACOR)","volume":"41","author":"Delgado","year":"2009","journal-title":"Transpl Proc"},{"key":"10.1016\/j.healun.2024.12.014_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.healun.2007.01.017","article-title":"Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up","volume":"26","author":"Rothenburger","year":"2007","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2017.12.005","article-title":"Long-term sirolimus for primary immunosuppression in heart transplant recipients","volume":"71","author":"Asleh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2024.12.014_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025507","article-title":"Characteristics, predictors, and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database","volume":"11","author":"Kampaktsis","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2024.12.014_bib22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.tp.0000276959.56959.69","article-title":"Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients","volume":"84","author":"Raichlin","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2024.12.014_bib24","doi-asserted-by":"crossref","first-page":"E649","DOI":"10.1111\/ctr.12241","article-title":"Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation","volume":"27","author":"Gonz\u00e1lez-V\u00edlchez","year":"2013","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/biostatistics\/kxx046","article-title":"Survival analysis with time-dependent covariates subject to missing data or measurement error: Multiple Imputation for Joint Modeling (MIJM)","volume":"19","author":"Moreno-Betancur","year":"2018","journal-title":"Biostatistics"},{"key":"10.1016\/j.healun.2024.12.014_bib26","article-title":"Variable selection strategies and its importance in clinical prediction modelling","volume":"8","author":"Chowdhury","year":"2020","journal-title":"Fam Med Community Health"},{"key":"10.1016\/j.healun.2024.12.014_bib27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1600-6143.2007.02142.x","article-title":"Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients","volume":"8","author":"Aliabadi","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib28","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.transproceed.2010.09.014","article-title":"Proliferation signal inhibitors in heart transplantation: a 5-year experience","volume":"42","author":"S\u00e1nchez-L\u00e1zaro","year":"2010","journal-title":"Transpl Proc"},{"key":"10.1016\/j.healun.2024.12.014_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.healun.2012.11.028","article-title":"Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus\/mycophenolate mofetil) after heart transplantation: 5-year results","volume":"32","author":"Kaczmarek","year":"2013","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2024.12.014_bib30","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/CIRCULATIONAHA.119.044924","article-title":"Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation: a population-based study","volume":"141","author":"Loupy","year":"2020","journal-title":"Circulation"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824020278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249824020278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:15:24Z","timestamp":1762355724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249824020278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1053249824020278"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.12.014","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and risk factors for rejection after conversion from calcineurin inhibitor to sirolimus-based immunosuppression in orthotopic heart transplant recipients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}